日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2)

乳腺癌耐药蛋白(BCRP/ABCG2)潜在生物标志物的鉴定和临床评价

Riselli, Andrew M; Yee, Sook Wah; Yang, Jia; Brett, Claire M; Trumbach, Kelsey; Zhou, Xujia; Liu, Renmeng; Liang, Xiaomin; Lai, Yurong; Huo, Runlan; Xue, Yongjun; Shen, Hong; Zhang, Lei; Yang, Xinning; Liu, Qi; Huang, Shiew-Mei; Giacomini, Kathleen M

Evaluating Pneumonitis Incidence in Patients with Non-small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data

利用真实世界数据和临床试验数据评估接受免疫疗法和/或化疗的非小细胞肺癌患者的肺炎发生率

Liu, Qi; Zhang, Chenan; Huang, Yue; Huang, Ruihao; Huang, Shiew-Mei; Larkins, Erin; Stapleford, Liza; Rivera, Donna R; Kluetz, Paul G; Wang, Shenggang; Zhu, Hao; Weese, James; Cromartie, Elizabeth; Teka, Mahder; Walters, Sheetal; Wolf, Frank; Brown, Thomas D

Participation of Older Adults in Clinical Trials for New Drug Applications and Biologics License Applications From 2010 Through 2019

2010年至2019年老年人参与新药申请和生物制品许可申请临床试验的情况

Lau, S W Johnny; Huang, Yue; Hsieh, Julie; Wang, Shenggang; Liu, Qi; Slattum, Patricia W; Schwartz, Janice B; Huang, Shiew-Mei; Temple, Robert

Cannabis for Medical Use: Clinical Pharmacology Perspectives on Scientific and Regulatory Challenges

医用大麻:临床药理学视角下的科学与监管挑战

Zhou, Zhu; Paine, Mary F; Spindle, Tory R; Huang, Shiew-Mei; Zhang, Lei

Transporters in Regulatory Science: Notable Contributions from Dr. Giacomini in the Past Two Decades

转运蛋白在调控科学中的应用:Giacomini 博士过去二十年来的杰出贡献

Zhang, Lei; Liu, Qi; Huang, Shiew-Mei; Lionberger, Robert

Do Inhibitory Metabolites Impact DDI Risk Assessment? Analysis of in vitro and in vivo Data from NDA Reviews Between 2013 and 2018

抑制性代谢物是否会影响药物相互作用风险评估?对2013年至2018年新药申请审查中体外和体内数据的分析

Steinbronn, Claire; Yang, Xinning; Yu, Jingjing; Dimova, Hristina; Huang, Shiew-Mei; Ragueneau-Majlessi, Isabelle; Isoherranen, Nina

Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine: Current Status and Emerging Trends

临床药理学、药物研发和精准医疗中的监管科学:现状与新兴趋势

Liu, Qi; Ahadpour, Mitra; Rocca, Mitra; Huang, Shiew-Mei

Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations

抗SARS-CoV-2药物再利用数据库:临床药理学考量

Zhang, Xinyuan; Yang, Yuching; Grimstein, Manuela; Liu, Guansheng; Kitabi, Eliford; Fan, Jianghong; Wang, Ying-Hong; Earp, Justin; Weaver, James L; Zhu, Hao; Liu, Jiang; Reynolds, Kellie S; Huang, Shiew-Mei; Wang, Yaning

3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration

3D细胞培养模型:药物药代动力学、安全性评估和监管考量

Wang, Hongbing; Brown, Paul C; Chow, Edwin C Y; Ewart, Lorna; Ferguson, Stephen S; Fitzpatrick, Suzanne; Freedman, Benjamin S; Guo, Grace L; Hedrich, William; Heyward, Scott; Hickman, James; Isoherranen, Nina; Li, Albert P; Liu, Qi; Mumenthaler, Shannon M; Polli, James; Proctor, William R; Ribeiro, Alexandre; Wang, Jian-Ying; Wange, Ronald L; Huang, Shiew-Mei

Connecting Hydroxychloroquine In Vitro Antiviral Activity to In Vivo Concentration for Prediction of Antiviral Effect: A Critical Step in Treating Patients With Coronavirus Disease 2019

将羟氯喹体外抗病毒活性与体内浓度联系起来预测抗病毒效果:治疗2019冠状病毒病患者的关键步骤

Fan, Jianghong; Zhang, Xinyuan; Liu, Jiang; Yang, Yuching; Zheng, Nan; Liu, Qi; Bergman, Kimberly; Reynolds, Kellie; Huang, Shiew-Mei; Zhu, Hao; Wang, Yaning